Pretreatment with CpG-oligonucleotides in a DSS-induced colitis mouse model results in increased anti-inflammatory cytokine (IL-10) and decreased pro-inflammatory cytokine (IFN-γ) levels, supporting the immune modulatory effect of CpG motifs (47). The gene discussed is IL10; the disease is colitis.